Brave Asset Management Inc Eli Lilly & CO Transaction History

Brave Asset Management Inc

$410 Million
Q3 2024

A detailed history of Brave Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Brave Asset Management Inc holds 1,878 shares of LLY stock, worth $1.48 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

1,878

Previous 1,878 -0.0%

Holding current value

$1.48 Million

Previous $1.7 Million 2.18%

% of portfolio

0.41%

Previous 0.43%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$724.87 - $909.04 $10,148 - $12,726	14 Added 0.75%	1,878 $1.7 Million
Q1 2024 Apr 29, 2024	BUY	$592.2 - $792.28 $38,493 - $51,498	65 Added 3.61%	1,864 $1.45 Million
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $66,173 - $78,010	-126 Reduced 6.55%	1,799 $1.05 Million
Q1 2023 Apr 12, 2023	BUY	$310.63 - $364.82 $30,752 - $36,117	99 Added 5.42%	1,925 $661,000
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $14,231 - $16,217	-48 Reduced 2.56%	1,826 $590,000
Q1 2022 Apr 22, 2022	SELL	$234.69 - $291.66 $18,071 - $22,457	-77 Reduced 3.95%	1,874 $537,000
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $11,080 - $13,635	-50 Reduced 2.5%	1,951 $451,000
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $8,216 - $10,636	-50 Reduced 2.44%	2,001 $374,000
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $10,966 - $12,684	-75 Reduced 3.53%	2,051 $304,000
Q3 2019 Oct 24, 2019	SELL	$106.79 - $116.16 $5,339 - $5,808	-50 Reduced 2.3%	2,126 $238,000
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $1.04 Million - $1.21 Million	-9,361 Reduced 81.14%	2,176 $241,000
Q1 2019 May 03, 2019	BUY	$111.31 - $131.02 $74,466 - $87,652	669 Added 6.16%	11,537 $1.5 Million
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $88,214 - $98,827	-833 Reduced 7.12%	10,868 $1.26 Million
Q3 2018 Oct 23, 2018	BUY	$85.86 - $107.31 $12,020 - $15,023	140 Added 1.21%	11,701 $1.26 Million
Q2 2018 Jul 23, 2018	BUY	$75.7 - $86.88 $49,205 - $56,472	650 Added 5.96%	11,561 $987,000
Q1 2018 Apr 26, 2018	BUY	$74.21 - $87.6 $6,382 - $7,533	86 Added 0.79%	10,911 $844,000
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $8,521 - $9,140	-104 Reduced 0.95%	10,825 $914,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $842,298 - $934,866	10,929	10,929 $935,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.

Account

Brave Asset Management Inc Eli Lilly & CO Transaction History